1 |
Austin K, Janagan S, Wells M, et al. ANCA associated vasculitis subtypes: recent insights and future perspectives[J]. J Inflamm Res, 2022, 15: 2567-2582.
|
2 |
王凯歌, 邹 晶, 谭 芬, 等. 肺脏受累的原发性抗中性粒细胞胞浆抗体相关性小血管炎43 例临床分析[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(6): 638-641.
|
3 |
Geetha D,Jefferson JA. ANCA-associated vasculitis: core curriculum 2020[J]. Am J Kidney Dis, 2020, 75(1): 124-137.
|
4 |
Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides[J].Arthritis Rheum, 2013, 65(1): 1-11.
|
5 |
Cornec D, Cornec-Le Gall E, Fervenza FC, et al. ANCA-associated vasculitis-clinical utility of using ANCA specificity to classify patients[J]. Nat Rev Rheumatol, 2016, 12(10): 570-579.
|
6 |
Trivioli G, Marquez A, Martorana D, et al. Genetics of ANCAassociated vasculitis: role in pathogenesis, classification and management[J]. Nat Rev Rheumatol, 2022, 18(10): 559-574.
|
7 |
田新平, 赵丽珂, 姜振宇, 等. 抗中性粒细胞胞质抗体相关血管炎诊疗规范[J]. 中华内科杂志, 2022, 61(10): 1128-1135.
|
8 |
Kronbichler A,Bajema IM,Bruchfeld A,et al.Diagnosis and management of ANCA-associated vasculitis[J]. Lancet, 2024, 403(10427):683-698.
|
9 |
Sreih AG, Cronin K, Shaw DG,et al. Diagnostic delays in vasculitis and factors associated with time to diagnosis[J]. Orphanet J Rare Dis, 2021, 16(1): 184.
|
10 |
Walker BS, Peterson LK, Koening C, et al. Performance of MPOANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis[J]. Autoimmun Rev, 2022, 21(6): 103100.
|
11 |
Robson JC, Grayson PC, Ponte C, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis [ J].Arthritis Rheumatol, 2022, 74(3): 393-399.
|
12 |
汤思微, 柏 明, 张 鹏. 抗中性粒细胞胞质抗体相关性血管炎诊治进展[J]. 临床肾脏病杂志, 2024, 24(3): 244-248.
|
13 |
Windpessl M, Bettac EL,Gauckler P,et al. ANCA status or clinical phenotype-What counts more? [J]. Curr Rheumatol Rep,2021,23(6): 37.
|
14 |
Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA-associated vasculitis[J]. N Engl J Med, 2012, 367(3): 214-223.
|
15 |
Guchelaar NAD, Waling MM, Adhin AA, et al. The value of antineutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and metaanalysis [J]. Autoimmun Rev, 2021, 20(1): 102716.
|
16 |
Salvador F. ANCA associated vasculitis[J]. Eur J Intern Med,2020, 74: 18-28.
|
17 |
Hong Y, Shi P, Liu X, et al. Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: A retrospective single-center study[J]. Clin Rheumatol, 2019, 38(6): 1665-1673.
|
18 |
Chen M,Yu F,Zhang Y,et al. Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides:a study of 426 patients from a single centre[J]. Postgrad Med J, 2005, 81(961): 723-727.
|
19 |
Kitching AR, Anders HJ,Basu N,et al. ANCA-associated vasculitis[J]. Nat Rev Dis Primers, 2020, 6(1): 71.
|
20 |
Kronbichler A,Shin JI,Lee KH,et al. Clinical associations of renal involvement in ANCA-associated vasculitis[J]. Autoimmun Rev,2020, 19(4): 102495.
|
21 |
Mohammad AJ,Segelmark M. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody( ANCA)-associated nephritis versus myeloperoxidase ANCAassociated nephritis[J]. J Rheumatol, 2014, 41(7): 1366-1373.
|
22 |
Villiger PM,Guillevin L.Microscopic polyangiitis:Clinical presentation[J]. Autoimmun Rev, 2010, 9(12): 812-819.
|
23 |
Yaseen K, Mandell BF. ANCA associated vasculitis (AAV): a review for internists [J]. Postgrad Med, 2023, 135(sup1): 3-13.
|
24 |
Yamagata M,Ikeda K,Tsushima K,et al.Prevalence and responsiveness to treatment of lung abnormalities on chest computed tomography in patients with microscopic polyangiitis: A multicenter, longitudinal,retrospective study of one hundred fifty consecutive hospital-based Japanese patients[J]. Arthritis Rheumatol, 2016, 68(3): 713-723.
|
25 |
Alba MA, Flores-Suárez LF, Henderson AG, et al. Interstital lung disease in ANCA vasculitis[J]. Autoimmun Rev, 2017, 16(7):722-729.
|
26 |
Ando Y, Okada F, Matsumoto S, et al. Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody ( MPOANCA)-related disease. CT findings in 51 patients[J]. J Comput Assist Tomogr, 2004, 28(5): 710-716.
|
27 |
孔令彦, 李 骁, 徐一铭, 等. 不同靶抗原抗中性粒细胞胞浆抗体相关性血管炎胸部CT 表现及临床分析[J]. 影像诊断与介入放射学, 2023, 32(5): 323-328.
|
28 |
Fouka E, Drakopanagiotakis F, Steiropoulos P. Pathogenesis of pulmonary manifestations in ANCA-Associated vasculitis and goodpasture syndrome[J]. Int J Mol Sci, 2024, 25(10): 5278.
|
29 |
Ananthakrishnan L, Sharma N, Kanne JP. Wegener′s granulomatosis in the chest: high-resolution CT findings [ J]. AJR Am J Roentgenol, 2009, 192(3): 676-682.
|
30 |
Quartuccio L, Bond M, Isola M, et al. Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors[J]. J Autoimmun, 2020, 108: 102397.
|